Search

Your search keyword '"Schaeverbeke, Thierry"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Schaeverbeke, Thierry" Remove constraint Author: "Schaeverbeke, Thierry" Database OpenAIRE Remove constraint Database: OpenAIRE
29 results on '"Schaeverbeke, Thierry"'

Search Results

1. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression

2. Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission

3. Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors.: Prospective cohort study

4. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome

5. Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries

6. Effectiveness of vedolizumab for Crohn's disease with spondyloarthritis in fail with two TNF blocking agents

7. Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

8. Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update

9. Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort

10. Anti-Porphyromonas gingivalis antibodies titres are associated with non-smoking status in early rheumatoid arthritis: Results from the ESPOIR cohort

11. Reply to the comment of Brinster et al. 'Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists'

12. Prevalence of Gout in the Adult Population of France

13. Additional file 1: of Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

14. Efficacy and Safety of Febuxostat in 55 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Results from a Retrospective Multicenter Study

15. Identification and Characterization of A Synovial Fluid Microbial DNA in Rheumatoid Arthritis Patients

16. Potential Classification Criteria for Rheumatoid Arthritis After Two Years: Results From a French Multicenter Cohort

17. Analysis of anti Porphyromonas gingivalis (P. gingivalis) antibodies in a large cohort of patients with an early arthritis (ESPOIR)

18. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.: Lymphoma complicating anti-TNF therapy

19. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.: Lymphoma complicating anti-TNF therapy

20. Evaluation of two strategies (initial methotrexate monotherapy versus its combination with adalimumab) in management of early active rheumatoid arthritis during the first year of evolution: data from the GEPARD trial

21. Rituximab (MabThera) therapy and safety management. Clinical tool guide

22. Evaluation of two strategies (initial methotrexate monotherapy versus its combination with adalimumab) in management of early active rheumatoid arthritis during the first year of evolution: Data from 3 the Guepard trial

23. TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology

26. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)

27. Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?

29. Microbiote intestinal et inflammation : prédiction de la réponse aux anti-TNFα dans les maladies inflammatoires chroniques et modulation de la croissance bactérienne in vitro en réponse au TNFα

Catalog

Books, media, physical & digital resources